Purchase Order HHSN275201700270P
Award Date
3/9/17
Potential Completion Date
11/20/17
Potential Value
$8K
Awardee
Genecopoeia, Inc.
Ultimate Awardee
Not listed
NAICS Category
541380 - Testing Laboratories and Services
PSC Category
Q301 - Reference Laboratory Testing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
2
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services' National Institutes of Health's National Institute for Minority Health and Health Disparities awarded a $530,904 firm fixed price delivery order contract to Medical Science & Computing, LLC. The purpose of this project is to provide clinical support for an infantile GM1 gene therapy clinical trial. The place of performance is Potomac, Maryland. The period of performance is from June 25, 2021 through August 30, 2022. No subcontractors or set...
This is a firm fixed-price purchase order contract awarded by the National Institute on Minority Health and Health Disparities (NIMHD), part of the National Institutes of Health, to Singulomics Corp, a biotechnology company. The $79,980 contract is for single-nucleus RNA sequencing services on 20 samples of triple-negative breast cancer tissue, including 10 from African American patients and 10 from European American patients. The purpose is to identify differences in immune cell profiles...
This contract was awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency within the U.S. Department of Health and Human Services, to Genecopoeia, Inc. Genecopoeia is a minority-owned, Asian-Pacific American-owned, for-profit manufacturer of goods registered to receive federal awards since 2006. The $16,500 firm-fixed-price purchase order does not have a set-aside designation. Genecopoeia, a provider of scientific research materials and services, is...
The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a firm fixed price purchase order to Cofactor Genomics, Inc., a minority-owned, self-certified small disadvantaged business, in the amount of $411,950.00. The contract is for the provision of DNA methylation libraries, Illumina sequencing, FASTQ raw sequence files, and Bismark summary files. The work is to be performed in St. Louis, Missouri, with a completion date of...
The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a $119,840.00 firm fixed price purchase order to Cofactor Genomics, Inc., a minority-owned, self-certified small disadvantaged business, for DNA methylation sequencing profiles. The contract has a completion date of August 29, 2023. Cofactor Genomics, Inc. will perform the work in St. Louis, Missouri. The contract award resulted from a solicitation posted on July 8, 2021,...
The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a $14,182 purchase order to Carahsoft Technology Corp. to provide telecommunications software and hardware operation, maintenance, and repair services. The single award firm fixed price contract will be performed in Bethesda, Maryland over a one year period concluding in July 2024. No subcontractors or set aside designations were identified. The National Human Genome...
This firm fixed-price purchase order for $18,204.88 was awarded by the Department of Health and Human Services' National Institutes of Health National Institute on Drug Abuse to Genscript USA Inc. to obtain cell lines utilizing CRISPR gene editing technology. Specifically, the contract calls for Genscript to generate knockout HEK293 and HepG2 cell lines of the MMAB and MUT genes to support studies for hereditary disorders of vitamin B12 and methylmalonic acid metabolism. No set-aside designation...
The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a $177,991.20 firm fixed price purchase order to Metabolon, Inc., a self-certified small disadvantaged business, for metabolomic profiling of individuals of African descent. The order was issued directly under a solicitation, without the use of a set-aside. Metabolon provides metabolomics services and solutions to government agencies, leveraging its proprietary technology...
<p>The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded a $249,648.00 firm fixed price purchase order to Medical Neurogenetics, LLC, a for-profit organization, for clinical genetic testing services. The contract has a completion date of November 2, 2023 and does not have a set-aside designation. The place of performance is Bethesda, Maryland.</p>
The Department of Health and Human Services' National Institutes of Health's National Institute of Child Health and Human Development awarded a $10,800 firm fixed price purchase order to Vaccine And Gene Therapy Institute Of Florida Corp. to provide GEN01, Illumina WG BeadChip, Complete 1-Cycle Assay. The place of performance will be in Bethesda, Maryland. The period of performance is from May 14, 2013 through September 30, 2013. No major subcontractors or set aside designations were...